Capital International Investors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,321,200
| Closed | -$5.63M | – | 459 |
|
|
2021
Q2 | $5.63M | Hold |
1,321,200
| – | – | ﹤0.01% | 435 |
|
|
2021
Q1 | $7.02M | Hold |
1,321,200
| – | – | ﹤0.01% | 423 |
|
|
2020
Q4 | $7.12M | Hold |
1,321,200
| – | – | ﹤0.01% | 416 |
|
|
2020
Q3 | $10.5M | Hold |
1,321,200
| – | – | ﹤0.01% | 395 |
|
|
2020
Q2 | $13.2M | Hold |
1,321,200
| – | – | ﹤0.01% | 369 |
|
|
2020
Q1 | $3.59M | Buy |
1,321,200
+694,200
| +111% | +$1.89M | ﹤0.01% | 373 |
|
|
2019
Q4 | $752K | Hold |
627,000
| – | – | ﹤0.01% | 381 |
|
|
2019
Q3 | $947K | Hold |
627,000
| – | – | ﹤0.01% | 387 |
|
|
2019
Q2 | $2.52M | Buy |
627,000
+233,000
| +59% | +$937K | ﹤0.01% | 381 |
|
|
2019
Q1 | $1.69M | Hold |
394,000
| – | – | ﹤0.01% | 378 |
|
|
2018
Q4 | $2.27M | Hold |
394,000
| – | – | ﹤0.01% | 370 |
|
|
2018
Q3 | $5.34M | Buy |
+394,000
| New | +$5.34M | ﹤0.01% | 362 |
|